FDA Adverse Event Injury Summary report: N

UNKNOWN KNEE FEMORAL

MDR report key: 9293864 · Received November 7, 2019

Report

Report Number
1818910-2019-114945
Event Type
Injury
Date Received
November 7, 2019
Date of Event
April 10, 2009
Report Date
October 22, 2019
Manufacturer
DEPUY ORTHOPAEDICS INC US
Product Code
JWH
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

PRODUCT COMPLAINT # (B)(4). INVESTIGATION SUMMARY ==> NO DEVICE WAS RECEIVED. ROOT CAUSE UNDETERMINED. DEPUY SYNTHES CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION MAY BE RE-OPENED AS NECESSARY. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

(B)(4). IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. (B)(4).

Description of Event or Problem · 1

LITERATURE ARTICLE RECEIVED ENTITLED: "REVISION TOTAL KNEE ARTHROPLASTY USING THE PFC SIGMA KNEE SYSTEM". LITERATURE ARTICLE "REVISION TOTAL KNEE ARTHROPLASTY USING THE PFC SIGMA KNEE SYSTEM" (2009) BY SIN WOO LIM, MAN SIK YOU, AND DONG HEON KIM PUBLISHED BY THE JOURNAL OF KOREAN KNEE SOCIETY WAS REVIEWED. THE ARTICLE PURPOSE: TO ANALYZE THE CAUSES, CLINICAL AND RADIOLOGICAL RESULTS OF REVISION SURGERY WITH PFC SIGMA KNEE IMPLANTS. THE ARTICLE REPORTS: FROM MARCH 1999 TO MAY 2005, 34 PATIENTS WHO COULD BE FOLLOWED-UP FOR MORE THAN 4 YEARS WERE THE SUBJECTS OF THIS STUDY. PFC SIGMA KNEE SYSTEM WAS USED IN ALL CASES. PATELLA REVISION WAS ONLY DONE IN CASES WHERE PATELLA "DAMAGE AND FIXATION IS POOR". THE ACTUAL EXTENT OF PATELLA RESURFACING WAS NOT DISCLOSED. THE MEAN KNEE SCORE IMPROVED FROM 45.1 POINTS PREOPERATIVELY TO 84.5 POINTS POSTOPERATIVELY, AND THE MEAN FUNCTIONAL SCORE IMPROVED FROM 37.2 POINTS PREOPERATIVELY TO 78.2 POINTS POSTOPERATIVELY. THE RANGE OF MOTION WAS INCREASED FROM PREOPERATIVE 97°TO POSTOPERATIVE 109°. THE SUBJECTIVE SATISFACTION WAS 8.2 POINTS. THERE WERE TWO CASES OF SUPERFICIAL INFECTION WHICH WERE TREATED SUCCESSFULLY SHORTLY POST-OPERATION. THERE WAS 1 CASE OF WOUND DEHISCENCE THAT WAS SUCCESSFULLY TREATED WITHIN THREE WEEKS WITH WASHING AND SKIN GRAFTING. OTHERWISE, THE REVISION SURGERIES PERFORMED IN THIS STUDY WERE OVERALL VERY SUCCESSFUL. DEPUY PRODUCTS INVOLVED: PFC SIGMA. COMPLICATIONS: IMPAIRED HEALING (1).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1088343 UNKNOWN KNEE FEMORAL KNEE FEMORAL JWH DEPUY ORTHOPAEDICS INC US NA

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention